The use of monoclonal antibody treatment
has shown positive results in battling other viruses such as HIV, MERS, Ebola and Zika. Learn the current applications for Sars-Cov-2 and the recommendations of the FDA emergency use authorization for best candidates for this treatment
- Monoclonal Antibodies and the impact of B-cell activation
- Which manufacturers are currently providing the offering
- How MAB’s are created and how they work
- Results of the BLAZE1 study
- Method of delivery to the patient
- Timeline for treatment
Check out Dr. Erik McLaughlin’s video on Monoclonal Antibodies, the mAb treatment and how it can help CoV-19 patients at high risk for hospitalization and death.
Of course, TB and COVID-19 share several clinical manifestations, meaning safety measures when dealing for either one must be rigorous and follow best practices. This includes use of respiratory infection control measures, sanitization of surfaces, handwashing, PPE, and careful collection and storage of all samples used.
At AB Med, accuracy is our highest priority, and everything we publish is up-to-date based on research and news at the time of release. However, due to the continually evolving nature of COVID-19, we are aware that available data changes quickly. The available data and recommendations may have changed since this article’s publication. Please check the CDC, WHO, and your local health department for the most current recommendations and news.
By: Erik McLaughlin MD, MPH and Aikaterini Papadopoulou, B.Arch Let’s Connect.